Rayegani, Seyed Mansoor
Soltani, Vahid
Cheraghi, Mohsen
Omid Zohor, Mohammad Reza
Babaei-Ghazani, Arash
Raeissadat, Seyed Ahmad
Article History
Received: 29 October 2022
Accepted: 20 April 2023
First Online: 29 April 2023
Declarations
:
: All patients signed written informed consent before enrollment. The Ethics Committee approved the study protocol of Shahid Beheshti University of Medical Sciences. In this study all methods were based on relevant guidelines and regulations (declaration of Helsinki).
: Not applicable.
: Not Applicable
: The Ethics Committee approved the study protocol of Shahid Beheshti University of Medical Sciences. The trial was registered on the Iranian Clinical trial Registry with identification number IRCT IRCT20090704002117N2 (registration date: 07/08/2019). Patients were able to leave the study at any time if they were reluctant to continue the trial. This study conforms to all CONSORT guidelines and reports the required information accordingly.